Filing Details
- Accession Number:
- 0000711377-19-000021
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-17 20:27:49
- Reporting Period:
- 2019-07-15
- Accepted Time:
- 2019-07-17 20:27:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
711377 | Neogen Corp | NEOG | In Vitro & In Vivo Diagnostic Substances (2835) | 382367843 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1168789 | L James Herbert | Neogen Corp 620 Lesher Place Lansing MI 48912 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-07-15 | 5,000 | $62.93 | 626,484 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-07-17 | 5,000 | $65.00 | 621,484 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- These shares were sold under the terms of a Rule 10b5-1 plan filed by the Reporting Person on February 12, 2019